Cancer / Oncology News From Medical News Today
Latest Cancer / Oncology News From Medical News Today.
- Last build:
- Language:
- en-us
- Feed URL:
- http://www.medicalnewstoday.com/rss/cancer-oncology.xml
RSS FEED IDEMS: Cancer / Oncology News From Medical News Today
- Breast Cancer: A Role For Trans Fatty Acids?
Two groups from INSERM and Institut Gustave Roussy collaborated to conduct an epidemiologic study on a cohort of French women members of the Mutuelle generale de l'Education nationale (E3N). The scientists showed that the risk of breast cancer was doubled in women having higher serum levels of trans fatty acids. The trans fatty acids studied are those from industrial sources (processed foods, processed bread, processed pastries, cakes, potato chips, pizza dough, etc.).
Mon, 14 Apr 2008 04:00:00 PDT - Molecule That Disrupts Ewing's Sarcoma Oncogene Found In Lab Study
Researchers at Georgetown University Medical Center have found a small molecule they say can block the action of the oncogene that causes Ewing's sarcoma, a rare cancer found in children and young adults. If further studies continue to prove beneficial, they say the novel agent could be the first targeted therapy to treat the disease, which can produce tumors anywhere in the body.
Mon, 14 Apr 2008 04:00:00 PDT - Risk To Older Australians Of Sun-Related Skin Cancer Death
A new Western Australian study has revealed the mortality from non-melanoma skin cancer (NMSC), commonly considered less dangerous than melanoma, is affecting older Australians at a worrying rate.Researchers at the Western Australian Institute for Medical Research (WAIMR) found West Australians above the age of 69, especially men, accounted for 70 percent of deaths from non-melanoma skin cancer in WA, and most primary cancers occured in areas of high sun exposure.
Mon, 14 Apr 2008 04:00:00 PDT - Illumina Introduces Three New Research Products To Study Genetic Variations Linked To Cancer Development
Illumina, Inc. (NASDAQ:ILMN) announced that it is making available three new product solutions for cancer research, which include expansion of Illumina's proprietary DASL® Assay to whole-genome profiling, and the launch of DASL focused expression and methylation profiling on Illumina's VeraCode® technology. These new solutions allow researchers to leverage synergies across Illumina technology platforms to better understand the complex molecular mechanisms that give rise to cancer.
Mon, 14 Apr 2008 04:00:00 PDT - Amrubicin Is Designated As An Orphan Medicinal Product By The European Commission For The Treatment Of Small Cell Lung Cancer
Celgene International Sarl (NASDAQ: CELG) announced that amrubicin hydrochloride has been designated as an orphan medicinal product by the European Commission (EC) for the treatment of small cell lung cancer following the favorable opinion of the European Medicines Agency's (EMEA) Committee for Orphan Medicinal Products (COMP).
Mon, 14 Apr 2008 03:00:00 PDT - Updated Data On Reata's Two Clinical Candidates Presented At 2008 Annual Meeting Of The American Association Of Cancer Research
Reata Pharmaceuticals, Inc. announced the presentation of significant new preclinical data on its two clinical-stage compounds, berubicin hydrochloride (an anthracycline derivative formerly known as RTA 744) and RTA 402 (the lead agent in Reata's portfolio of Antioxidant Inflammation Modulators, or AIMs, also known as CDDO-Me). On April 15, researchers from The University of Texas M. D.
Mon, 14 Apr 2008 03:00:00 PDT - Landon Foundation-AACR INNOVATOR Awards
Reinforcing its commitment to supporting high-quality cancer research, the Kirk A. and Dorothy P. Landon Foundation have again partnered with the American Association for Cancer Research (AACR) to create two new funding opportunities, the Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research and the Landon Foundation-AACR INNOVATOR Award for International Collaboration in Cancer Research.
Mon, 14 Apr 2008 03:00:00 PDT - Cell Genesys Announces Encouraging Results From Phase 1/2 Trial Of GVAX Immunotherapy For Prostate Cancer In Recurrent Disease
Cell Genesys, Inc. (Nasdaq:CEGE) announced data from a completed Phase 1/2 clinical trial (G-9802) of GVAX immunotherapy for prostate cancer in men with recurrent prostate cancer who had not yet received treatment with hormone replacement therapy following relapse after prostate cancer surgery and/or radiation therapy.
Mon, 14 Apr 2008 02:00:00 PDT - Scientists Investigate A Fine Balancing Act Between Stem Cells And Cancer
Speaking at the UK National Stem Cell Network Annual Science Meeting in Edinburgh, Professor Silvia Marino showed how the mechanisms normally involved in balancing different functions of stem cells may also contribute to cancer. Her team from Barts and the London School of Medicine and Dentistry is currently delving into these mechanisms to understand how stem cells are normally regulated and what role they may play in malignant brain tumours.
Mon, 14 Apr 2008 02:00:00 PDT - Drug Protects Cells From Radiation
A drug that protects healthy cells from radiation as been found, The Guardian reports. The drug "could improve the effectiveness of radiation therapy in treating cancer and help prevent radiation sickness after exposure to a nuclear accident or attack," the newspaper adds. The story is based on a study in mice and monkeys of a new drug called Protectan CBLB502.
Mon, 14 Apr 2008 02:00:00 PDT - Further Research On Resveratrol Shows Promise For Treatment Of Pancreatic Cancer
Baywood International, Inc. (OTCBB:BAYW) ("Company") announced that resveratrol, the antioxidant found in grape skins and red wine, can cripple the function of pancreatic cancer cells while sensitizing them to chemotherapy, says new research.
Mon, 14 Apr 2008 02:00:00 PDT - Calling For Walkers To Step Out And Make A Difference For Mouth Cancer
Every 3 hours someone dies from Mouth Cancer. Mouth Cancer kills 1 in 2 people diagnosed due to late detection.Mouth Cancers have a higher proportion of deaths per number of cases than breast cancer, cervical cancer or skin melanoma. These are the shocking facts from the Mouth Cancer Foundation who are determined to raise awareness for the cancer about which little is known and they need your/dental professionals/health care professionals/etc etc help.
Mon, 14 Apr 2008 01:00:00 PDT - Researchers Find That Targeted Therapy Combination Overcomes Treatment Resistance In Liver Cancer
Researchers at the University of Pennsylvania School of Medicine and Abramson Cancer Center reported at the annual meeting of the American Association for Cancer Research that combining two targeted therapies overcomes treatment resistance in liver cancer cell lines. The team is currently designing a trial to test the combination in patients.Liver cancer is resistant to many chemotherapies and to cell-death inducing agents. Last year, however, the U.S.
Mon, 14 Apr 2008 00:00:00 PDT - Biomarkers Allow Doctors To Match Therapy To Patient
Genetic variations ensure that no two people are exactly alike, nor are their cancers. Researchers now have the tools and the knowledge to predict how individuals will respond to cancer therapy, enabling more precise and effective treatment.
Mon, 14 Apr 2008 00:00:00 PDT - How What And How Much We Eat (And Drink) Affects Our Risk Of Cancer
A healthy diet and lifestyle protect against a wide range of diseases, and new research presented at the American Association for Cancer Research 2008 Annual Meeting, April 12-16, shows that cancer is no exception. Researchers demonstrate how excessive alcohol drinking could lead to an increased risk of breast cancer, how consuming too many calories may increase one's risk formelanoma, and why with folic acid, timing is everything for colon cancer prevention.
Mon, 14 Apr 2008 00:00:00 PDT
